SMC4 and central nervous system cancer: Our multi-omics analysis across multiple datasets (TCGA, CGGA, GEO, ProteinAtlas) revealed consistent upregulation of SMC4 in glioma tissues, with expression levels correlating with tumor grade and patient prognosis (Figure 1; Supplementary Figure 1).